Debiopharm
Group develops and markets pharmaceutical products for immunology, metabolism, oncology and infectious diseases... Read moreDebiopharm
Group develops and markets pharmaceutical products for immunology, metabolism, oncology and infectious diseases... Read more
News
Partnership
Feb 25, 2025
FinanzNachrichten
MEDSIR & Debiopharm Announce the First Patient Dosed in the WIN-B Trial Exploring the Combination of Debio 0123 & Gilead's Trodelvy in Advanced Breast Cancer
investment
Nov 27, 2024
https://siliconcanals.com/raidium-bags-16m-funding/
Debiopharm Group has invested $17M in Raidium
Debiopharm Competitors
1
2
3
4
5
6
7
8
9
10